Sigma-Aldrich Posts 6 Percent Q2 Growth | GenomeWeb

NEW YORK (GenomeWeb News) – Sigma-Aldrich today reported second-quarter revenue growth of 6 percent, with increases coming from all of its reporting units.

The St. Louis-based chemicals and research products firm reported total revenues of $554 million for the three-month period ended June 30, compared to $522 million for the second quarter of 2009. Excluding the impact of currency exchange, Sigma-Aldrich's sales were up 7 percent for the quarter.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.